Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the England Rare Diseases Action Plan 2022, published on 28 February, when the strategic approach on Advanced Therapy Medicinal Products will be published; and what engagement is being carried out as part of its development.

NHS England is continuing to develop its strategic approach on Advanced Therapy Medicinal Products (ATMPs), informed by engagement with patients, providers and the pharmaceutical industry. This is focused on the commissioning and implementation of ATMPs, including service readiness, redesign, investment and provider selection. While no formal publication is currently planned, progress will be reported in England’s Rare Diseases Action Plans.